Thomas Jaecklin

Title: Thomas Jaecklin: Innovator in Cholestasis Treatment

Introduction

Thomas Jaecklin is a notable inventor based in Delemont, Switzerland. He has made significant contributions to the field of liver disease treatment, particularly in methods for addressing cholestasis. With a total of 5 patents to his name, Jaecklin's work is paving the way for innovative therapeutic approaches.

Latest Patents

Jaecklin's latest patents focus on methods for treating cholestasis in subjects suffering from liver diseases. One of his key inventions involves the administration of an Apical Sodium-dependent Bile Acid Transporter (ASBTI) to patients. Specifically, the method includes administering an ASBTI at a dose of at least 10 μg/kg/day, which has shown promise in alleviating the symptoms associated with cholestasis.

Career Highlights

Throughout his career, Thomas Jaecklin has been associated with Mirum Pharmaceuticals, Inc., where he continues to develop innovative solutions for liver disease. His expertise and dedication to research have positioned him as a leading figure in the medical community.

Collaborations

Jaecklin collaborates with fellow professionals, including Alejandro Dorenbaum, to enhance the development of effective treatments for liver conditions. Their combined efforts contribute to advancing the understanding and management of cholestasis.

Conclusion

In summary, Thomas Jaecklin is a distinguished inventor whose work in cholestasis treatment is making a significant impact in the field of liver disease. His innovative methods and collaborations are essential in the pursuit of effective therapies.